EUVIMEDEUVIMED entdecken
Crossref

Update on the prevention and treatment of tumor lysis syndrome

Krishna Sury

Journal of Onco-Nephrology · 2019

DOI: 10.1177/2399369319837212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Onco-Nephrology, 2019. Verfasst von Krishna Sury. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 130 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor lysis syndrome is a constellation of metabolic derangements seen when tumor cells die and release their intracellular contents into the systemic circulation. Hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia may lead to severe organ dysfunction and even death. Tumor lysis syndrome is classically considered a complication of successful cancer treatment, but it can also occur in untreated malignancies characterized by rapid proliferation. In this review, we cover the types of cancers and chemo- and immunotherapies associated with tumor lysis syndrome, the mechanisms by which severe metabolic derangements can develop, and the available treatments.

Zitieren

APA

Sury, K. (2019). Update on the prevention and treatment of tumor lysis syndrome. Journal of Onco-Nephrology. https://doi.org/10.1177/2399369319837212

Vancouver

Sury K. Update on the prevention and treatment of tumor lysis syndrome. Journal of Onco-Nephrology. 2019. doi:10.1177/2399369319837212

BibTeX
@article{Sury2019,
  author = {Sury, Krishna},
  title = {Update on the prevention and treatment of tumor lysis syndrome},
  journal = {Journal of Onco-Nephrology},
  year = {2019},
  doi = {10.1177/2399369319837212}
}
Kostenlos starten →